PharmaShots | Incisive News in 3 Shots

Subscribe Now

diabetes

Dr. Navdeep Tangri & Helen Yeh Shares Insights from the Data Presented at ASN Kidney Week 2022 on the Importance of Earlier Screening & Diagnosis of Chronic Kidney Disease

Dr. Navdeep Tangri & Helen Yeh Shares Insights from the Data Presented at ASN Kidney Week 2022 on the Importance of Earlier Screen...

November 21, 2022

Glenmark launches Remogliflozin + Vildagliptin + Metformin as Fixed Dose Combination for the Treatment of Type 2 Diabetes in India

Glenmark launches Remogliflozin + Vildagliptin + Metformin as Fixed Dose Combination for the Treatment of Type 2 Diabetes in India

October 26, 2021

PharmaShots Interview: Zealand Pharma's Dr. David Kendall Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Adult Patients with Diabetes

PharmaShots Interview: Zealand Pharma's Dr. David Kendall Shares Insights on Zegalogue for Severe Hypoglycemia in Pediatric and Ad...

September 27, 2021

CVS Dropped Sanofi's Diabetes Drugs Lantus for Biosimilars

CVS Dropped Sanofi's Diabetes Drugs Lantus for Biosimilars

August 13, 2021

Viatris and Biocon's Semglee (biosimilar- insulin glargine) Receive the US FDA's Approval as the First Interchangeable Biosimilar for Diabetes

Viatris and Biocon's Semglee (biosimilar- insulin glargine) Receive the US FDA's Approval as the First Interchangeable Biosimilar...

July 29, 2021

The US FDA's EMDAC Supports Provention Bio's Teplizumab in Delaying Diabetes

The US FDA's EMDAC Supports Provention Bio's Teplizumab in Delaying Diabetes

May 28, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us